Omnicell, Inc.
OMCLNASDAQHealthcare● Active
$42.02
$-0.98(-2.28%)
Market Cap$1.9B
P/E Ratio—
52W High$55
52W Low$26.85
Omnicell, Inc. (OMCL) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OMCL · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 28, 2026EPS Actual
$0.55
Est. $0.33 · +66.7%
Revenue
$0.31B
Est. $0.30B · +1.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 28, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
OMCL reports quarterly as a NASDAQ-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | $0.48 | — | — | — | $0.31B | — |
| ▲ Q2 FY2026 | Apr 28, 2026 | $0.33 | $0.55 | +66.7% | $0.31B | $0.30B | +1.9% |
| ▼ Q1 FY2026 | Feb 5, 2026 | $0.47 | $0.40 | -14.9% | $0.31B | $0.31B | +0.2% |
| ▲ Q4 FY2025 | Oct 30, 2025 | $0.36 | $0.51 | +41.7% | $0.31B | $0.31B | -0.9% |
| ▲ Q3 FY2025 | Jul 31, 2025 | $0.31 | $0.45 | +45.2% | $0.29B | $0.29B | -0.5% |
| ▲ Q2 FY2025 | May 6, 2025 | $0.16 | $0.26 | +62.5% | $0.27B | $0.28B | -3.0% |
| ▲ Q1 FY2025 | Feb 6, 2025 | $0.57 | $0.60 | +5.3% | $0.31B | $0.30B | +3.0% |
| ▲ Q4 FY2024 | Oct 30, 2024 | $0.41 | $0.56 | +36.6% | $0.28B | $0.30B | -5.2% |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
$0.48
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 28, 2026Beat
EPS Actual
$0.55
EPS Est.
$0.33
EPS Surpr.
+66.7%
Revenue
$0.31B
Q1 FY2026
Feb 5, 2026Miss
EPS Actual
$0.40
EPS Est.
$0.47
EPS Surpr.
-14.9%
Revenue
$0.31B
Q4 FY2025
Oct 30, 2025Beat
EPS Actual
$0.51
EPS Est.
$0.36
EPS Surpr.
+41.7%
Revenue
$0.31B
Q3 FY2025
Jul 31, 2025Beat
EPS Actual
$0.45
EPS Est.
$0.31
EPS Surpr.
+45.2%
Revenue
$0.29B
Q2 FY2025
May 6, 2025Beat
EPS Actual
$0.26
EPS Est.
$0.16
EPS Surpr.
+62.5%
Revenue
$0.27B
Q1 FY2025
Feb 6, 2025Beat
EPS Actual
$0.60
EPS Est.
$0.57
EPS Surpr.
+5.3%
Revenue
$0.31B
Q4 FY2024
Oct 30, 2024Beat
EPS Actual
$0.56
EPS Est.
$0.41
EPS Surpr.
+36.6%
Revenue
$0.28B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.69 | $0.70 | $0.71 | 2 |
| Q3 FY2028 | $0.65 | $0.66 | $0.67 | 2 |
| Q2 FY2028 | $0.60 | $0.61 | $0.62 | 2 |
| Q1 FY2028 | $0.33 | $0.33 | $0.33 | 2 |
| Q4 FY2027 | $0.58 | $0.59 | $0.60 | 1 |
| Q3 FY2027 | $0.55 | $0.56 | $0.56 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.4B | $0.4B | $0.4B | 1 |
| Q3 FY2028 | $0.4B | $0.4B | $0.4B | 1 |
| Q2 FY2028 | $0.3B | $0.4B | $0.4B | 1 |
| Q1 FY2028 | $0.3B | $0.4B | $0.4B | 1 |
| Q4 FY2027 | $0.3B | $0.3B | $0.3B | 2 |
| Q3 FY2027 | $0.3B | $0.3B | $0.3B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 28, 2026 | +66.7% | $37.63 | $45.51 | +20.94% |
| ▼ Q1 FY2026 | Feb 5, 2026 | -14.9% | $46.69 | $39.08 | -16.30% |
| ▲ Q4 FY2025 | Oct 30, 2025 | +41.7% | $29.57 | $33.58 | +13.56% |
| ▲ Q3 FY2025 | Jul 31, 2025 | +45.2% | $29.70 | $31.01 | +4.41% |
| ▲ Q2 FY2025 | May 6, 2025 | +62.5% | $30.49 | $25.66 | -15.84% |
| ▲ Q1 FY2025 | Feb 6, 2025 | +5.3% | $44.38 | $39.43 | -11.15% |
| ▲ Q4 FY2024 | Oct 30, 2024 | +36.6% | $40.12 | $53.05 | +32.23% |
| ▲ Q3 FY2024 | Aug 1, 2024 | +218.8% | $29.21 | $38.85 | +33.00% |
Q2 FY2026+20.94%
Report Date
Apr 28, 2026
EPS Beat/Miss
+66.7%
Price Before
$37.63
Price After
$45.51
Q1 FY2026-16.30%
Report Date
Feb 5, 2026
EPS Beat/Miss
-14.9%
Price Before
$46.69
Price After
$39.08
Q4 FY2025+13.56%
Report Date
Oct 30, 2025
EPS Beat/Miss
+41.7%
Price Before
$29.57
Price After
$33.58
Q3 FY2025+4.41%
Report Date
Jul 31, 2025
EPS Beat/Miss
+45.2%
Price Before
$29.70
Price After
$31.01
Q2 FY2025-15.84%
Report Date
May 6, 2025
EPS Beat/Miss
+62.5%
Price Before
$30.49
Price After
$25.66
Q1 FY2025-11.15%
Report Date
Feb 6, 2025
EPS Beat/Miss
+5.3%
Price Before
$44.38
Price After
$39.43
Q4 FY2024+32.23%
Report Date
Oct 30, 2024
EPS Beat/Miss
+36.6%
Price Before
$40.12
Price After
$53.05
Q3 FY2024+33.00%
Report Date
Aug 1, 2024
EPS Beat/Miss
+218.8%
Price Before
$29.21
Price After
$38.85
Avg Beat Reaction+11.02%
Avg Miss Reaction-16.30%
Beat Rate7 / 8 quarters
Largest Move+33.00% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OMCL ends December
Omnicell, Inc. (OMCL) most recently reported earnings on April 28, 2026 for Q2 FY2026, posting EPS of $0.55 — beating the analyst consensus of $0.33 by +66.7%. The next OMCL earnings date is expected around September 1, 2026.
Each quarter, investors track OMCL earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OMCL revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OMCL's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OMCL earnings · 5 questionsOmnicell, Inc.'s next earnings report is expected around September 1, 2026. OMCL typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OMCL historically reports after market close (AMC).
OMCL earnings datewhen is OMCL earningsOMCL next earnings datewhen does OMCL report earningsOMCL earnings calendar
▸ Source: FMP · Omnicell, Inc. SEC filings · US GAAP · Omnicell, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026